Paola Lago
Advanced in Paris-Trousseau Thrombocytopenia

Paola Lago

Treviso, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Paris-Trousseau Thrombocytopenia
Treviso, IT 
OverviewLocationsClinical Research

Overview

Paola Lago practices in Treviso, Italy. Ms. Lago is rated as an Advanced expert by MediFind in the treatment of Paris-Trousseau Thrombocytopenia. Her top areas of expertise are Infant Respiratory Distress Syndrome, Intraventricular Hemorrhage of the Newborn, Premature Infant, and Infantile Pneumothorax.

Her clinical research consists of co-authoring 61 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Paris-Trousseau Thrombocytopenia.

Gender
Female

Locations

Treviso, 31100, Italy
Other Locations
Padova, Italy
Pavia, Italy
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drug: SHP607
Study Phase: Phase 2
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Enrollment Status: Terminated
Publish Date: March 24, 2023
Intervention Type: Other
Paracetamol Versus Ibuprofen for Patent Ductus Arteriosus Closure in Preterm Infants. A Prospective, Randomized, Controlled, Double Blind, Multicenter Clinical Trial.
Paracetamol Versus Ibuprofen for Patent Ductus Arteriosus Closure in Preterm Infants. A Prospective, Randomized, Controlled, Double Blind, Multicenter Clinical Trial.
Enrollment Status: Suspended
Publish Date: November 04, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trial

61 Total Publications

Current practices in neonatal pain management: a decade after the last Italian survey.
Current practices in neonatal pain management: a decade after the last Italian survey.
Journal: Italian journal of pediatrics
Published: October 03, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lago's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile